VEGF-D Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
Synonyms
FIGF; VEGFD.
Gene ID
2277
Swiss Prot
O43915
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
VEGF-D
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human VEGF D
Applications
WB, IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
2277
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
HK300075 200 Reactions
MIR1255a Human qPCR Template Standard (MI0006389)
Sign In for Pricing
View Details MBS6433519-01 0.1 mL
PSMA4 (Proteasome Alpha 4, HC9, PSC9, HsT17706) (MaxLight 405)
Sign In for Pricing
View Details MBS6433519-02 5x 0.1 mL
PSMA4 (Proteasome Alpha 4, HC9, PSC9, HsT17706) (MaxLight 405)
Sign In for Pricing
View Details